Showing results (21-30 of 38) with videos related to
Sort By:
Pageof 4
Archives of Physical Medicine and Rehabilitation|April 17, 2012
Balance and balance self-efficacy are associated with activity and participation after stroke: a cross-sectional study in people with chronic strokeArlene A Schmid, Marieke Van Puymbroeck, Peter A Altenburger, et al.Pharmacology Research & Perspectives|June 1, 2019
Application of ultrasound-guided cholecystocentesis to the evaluation of the metabolite profiling in bile of dogs and cynomolgus monkeysElizabeth A Dierks, Chiuwa E Luk, Hong Cai, et al.The American Journal of Cardiology|April 6, 1999
A new mutation in the elastin gene causing supravalvular aortic stenosisT Boeckel, A Dierks, A Vergopoulos, et al.Stroke|July 28, 2012
Poststroke balance improves with yoga: a pilot studyArlene A Schmid, Marieke Van Puymbroeck, Peter A Altenburger, et al.Journal of Medicinal Chemistry|November 19, 2024
Prodrug Strategy to Address Impaired Oral Absorption of a Weakly Basic TYK2 Inhibitor Caused by a Gastric Acid-Reducing AgentMurugaiah A M Subbaiah, Thangeswaran Ramar, Maheswara Reddy, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|September 6, 2015
Rosuvastatin Liver Partitioning in Cynomolgus Monkeys: Measurement In Vivo and Prediction Using In Vitro Monkey Hepatocyte UptakeBridget L Morse, Hong Cai, Jamus G MacGuire, et al.Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 23, 1998
Structure-function of cytochromes P450 and flavin-containing monooxygenases: implications for drug metabolismJ R Halpert, T L Domanski, O Adali, et al.ACS Medicinal Chemistry Letters|June 16, 2022
Discovery of Heteroaryl Urea Isosteres for Formyl Peptide Receptor 2 AgonistsNicholas R Wurtz, James A Johnson, Andrew Viet, et al.ACS Pharmacology & Translational Science|October 21, 2022
Molecular Mechanisms of Desensitization Underlying the Differential Effects of Formyl Peptide Receptor 2 Agonists on Cardiac Structure-Function Post Myocardial InfarctionJohn Lupisella, Stéphane St-Onge, Marilyn Carrier, et al.Journal of Medicinal Chemistry|March 5, 2008
Optimization of a dihydropyrrolopyrazole series of transforming growth factor-beta type I receptor kinase domain inhibitors: discovery of an orally bioavailable transforming growth factor-beta receptor type I inhibitor as antitumor agentHong-Yu Li, William T McMillen, Charles R Heap, et al.Pageof 4